An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published in November 2008 |
| Author/s |
author: Antonió Manuel Ferreira Araújo |
| Publication date | November 1, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |